UNITED THERAPEUTICS Corp 4

Ray Kurzweil acquired 650 shares of United Therapeutics Corp common stock via RSU vesting on July 9, 2026.

On July 9, 2026, United Therapeutics Corp insider Ray Kurzweil acquired 650 shares of common stock upon the vesting and settlement of restricted stock units (RSUs), which converted on a one-for-one basis into common shares at no exercise price. The transaction, coded as an RSU-related acquisition (transaction code M with an "A" acquisition flag), reflects routine equity compensation rather than an open-market purchase or sale, and resulted in 13,320 shares of common stock owned directly after the transaction. As the RSUs had no exercise price and there is no contemporaneous market price provided in the filing, the aggregate transaction value and the post-transaction value of his total holdings must be inferred from external market prices, which are not available in the provided data.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001108501-26-000002

Alert Tier

5